Related Experiment Video
Updated: Jul 4, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
The E525K β-Myosin Mutation Causes Hypocontractility in Cardiomyocytes Without Altering Loaded Crossbridge Cycling
Kalen Z Robeson1,2,3, Timothy S McMillen2,3,4, Kristina Kooiker2,3,5
1Department of Bioengineering, University of Washington, Seattle, WA, USA.
The MYH7 E525K mutation reduces cardiomyocyte contraction by disrupting myofibril organization, not by altering myosin crossbridge cycling. This study reveals structural deficits cause force loss in dilated cardiomyopathy models.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Biophysics
Background:
- The MYH7 E525K mutation is linked to dilated cardiomyopathy (DCM).
- Previous studies suggest this mutation stabilizes the myosin interacting heads motif (IHM), potentially affecting motor function.
- Direct measurements of contractile function in cardiomyocytes and engineered tissues were lacking.
Purpose of the Study:
- To investigate the functional consequences of the MYH7 E525K mutation in human induced pluripotent stem cell (iPSC)-derived cardiomyocytes.
- To determine how this mutation impacts force generation, contractile kinetics, and myofibrillar structure across multiple scales.
Main Methods:
- Engineered iPSC-derived cardiomyocytes and engineered heart tissues (EHTs) for heterozygous E525K expression.
- Measured isometric twitch force, maximal isometric force, and contractile kinetics (force development, relaxation, ADP release).
- Performed structural analysis of myofibrils, including content and organization (z-disk dispersion).
Main Results:
- E525K cardiomyocytes showed reduced contraction (65%) and EHTs showed decreased isometric twitch force (39%).
- Isolated myofibrils exhibited increased maximal isometric force (45%) but no change in force kinetics.
- Structural analysis revealed decreased myofibril content and increased z-disk dispersion in E525K cells.
Conclusions:
- The MYH7 E525K mutation impairs cardiomyocyte contractility primarily through reduced sarcomere number and myofibrillar disorganization.
- Myosin crossbridge cycling kinetics are not altered under load by the E525K mutation.
- Multi-scale analysis is crucial for understanding the complex functional impact of sarcomeric protein mutations in heart disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cross-bridge Cycle
Cardiomyopathy I: Introduction and Classification
The Role of Actin and Myosin in Non-muscle Cells
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...

